Aksys Ltd. to Present at Piper Jaffray Healthcare Conference.
PIPER JAFFRAY HEALTHCARE CONFERENCE, NEW YORK, Feb. 4 /PRNewswire/ -- Aksys, Ltd., founded in January 1991, is developing a breakthrough personalized hemodialysis (PHD(TM)) system which will greatly improve the health, quality of life, and disease management of patients with End Stage Renal Disease (ESRD). By using proprietary technology to overcome limitations of current dialysis methods, Aksys has created a completely automated and exceptionally user friendly dialysis system for frequent use at home or at a limited care facility. With the Aksys PHD(TM) system, patients with ESRD will have, for the first time, use of a simple and reliable personalized hemodialysis system which offers significant economic and clinical advantages over in-center hemodialysis and home peritoneal dialysis (PD). Aksys completed its IPO in May of 1996, raising $53 million. This will enable the Company to complete product development, clinical evaluation, regulatory filings and launch the product in the second half of 1999 in the U.S. and/or Europe.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 4, 1999|
|Previous Article:||Exigent's OS/COMET Selected for DataLynx; New System Provides High-Quality, Low Cost Satellite Support.|
|Next Article:||Vital Images, Inc. Places Vitrea(R) Software With Massachusetts General Hospital.|